Weighing the risks: new review ranks antidepressants by their physical health side effects

Drug,Abuse,Icon,With,Pills,,Outlined,Design

Antidepressants can help millions of people recover from depression and anxiety, but how do they affect physical health? Out today, a review in The Lancet compared 30 antidepressants to see which ones are most (and least) likely to increase our risk of heart disease, stroke, diabetes etc.

[read the full story...]

Physical health side effects of psychotropic medication: holistic prevention and management

Medicine warning sign, beware of drugs side effects, vector design of medical precaution illustration

From weight gain to heart rhythm changes, sexual dysfunction to sleep problems — the physical side effects of psychiatric drugs are vast, complex, and often overlooked. This blog distils key insights from a new Lancet Commission published today; to help clinicians and patients make safer, more informed prescribing decisions.

[read the full story...]

Immersive virtual reality for the treatment of mental health disorders: anxiety leads the way

adria-garcia-sarceda-O560d5Mnc04-unsplash

Rena Gatzounis blogs about a systematic review and meta-analysis investigating the effectiveness of immersive virtual reality treatments for mental health disorders.

[read the full story...]

Anticholinergics are associated with worse cognition: it’s time to take a serious look at our prescribing

A lot of pills in a pile

Eleanor Dawkins explores a new review and meta-analysis suggesting that cognitive impairment is linked with anticholinergic medication in psychosis, providing grounds for more careful monitoring and review of medications.

[read the full story...]

Antidepressants and suicide – it’s complicated…

Aerial,Top,Down,View,Of,People,Trying,To,Find,Exit

Rina Dutta and Alina Cuhraja summarise a network meta-analysis on antidepressants, suicidal ideation and suicidal behaviours, which suggests that SSRIs may reduce suicidal ideation in the short-term, but this is not sustained even to week 8 of treatment.

[read the full story...]

Hormonal coil dosage and depression risk

Female,Contraceptive,Spiral,In,The,Hands,Of,A,Nurse.,Device

Dr Rachel Reid-McCann discusses the latest research on dosage of levonorgestrel-releasing intrauterine system (LNG-IUS) and the risk of depression. A well conducted study from Denmark “provides evidence of a dose-dependent association between LNG exposure and risk of subsequent depression across three dosages”.

[read the full story...]

Psychotropic medication during pregnancy: new umbrella review finds no convincing evidence of adverse health outcomes for the baby

Featured

Flo Martin summarises a recent umbrella review which finds that we still have limited knowledge about the safety of psychotropic drug use in pregnancy.

[read the full story...]

Antidepressant discontinuation symptoms: what do the data really tell us?

julia-zolotova-5ZofAm1f27E-unsplash

Gemma Lewis and Glyn Lewis summarise a robust systematic review and meta-analysis investigating the incidence of symptoms when discontinuing or withdrawing from antidepressants. The data suggest that 8-14% of patients will experience antidepressant discontinuation symptoms, and for around 2% these symptoms will be severe.

[read the full story...]

Jury remains out on antidepressant-induced mania, despite findings of Danish trial emulation

nastya-dulhiier-x2cooe_MaG8-unsplash

Michael Kalfas and Paul Leeks summarise a recent Danish study that assesses the risk of antidepressant-induced mania in patients with bipolar depression.

[read the full story...]

Articaine v lidocaine for third molar removal

shutterstock_37849495

This review comparing the effectiveness of articaine and lidocaine for lower third molar surgery included 14 RCTs. The findings suggest that articaine is superior to lidocaine for use in lower third molar however the available are small so additional larger high quality studies would be helpful to strengthen the evidence.

[read the full story...]